British pharma innovation FTW
Source:
http://www.myfoxdc.com/dpp/news/offb...m-ncxdc-060811
Quote:
he new varieties contain enhanced levels of therapeutic compounds, including an appetite suppressant cannabinoid called THCV, which the company hopes will be used in the treatment of type 2 diabetes, obesity and other metabolic disorders.
Read more: http://www.myfoxdc.com/dpp/news/offb...#ixzz1OiSIls7q
|